199 related articles for article (PubMed ID: 37219662)
1. A Carboxy-terminal Smarcb1 Point Mutation Induces Hydrocephalus Formation and Affects AP-1 and Neuronal Signalling Pathways in Mice.
Brugmans AK; Walter C; Moreno N; Göbel C; Holdhof D; de Faria FW; Hotfilder M; Jeising D; Frühwald MC; Skryabin BV; Rozhdestvensky TS; Wachsmuth L; Faber C; Dugas M; Varghese J; Schüller U; Albert TK; Kerl K
Cell Mol Neurobiol; 2023 Oct; 43(7):3511-3526. PubMed ID: 37219662
[TBL] [Abstract][Full Text] [Related]
2. Mutations in SMARCB1 and in other Coffin-Siris syndrome genes lead to various brain midline defects.
Filatova A; Rey LK; Lechler MB; Schaper J; Hempel M; Posmyk R; Szczaluba K; Santen GWE; Wieczorek D; Nuber UA
Nat Commun; 2019 Jul; 10(1):2966. PubMed ID: 31273213
[TBL] [Abstract][Full Text] [Related]
3. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours.
Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ
Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms by which SMARCB1 loss drives rhabdoid tumor growth.
Kim KH; Roberts CW
Cancer Genet; 2014 Sep; 207(9):365-72. PubMed ID: 24853101
[TBL] [Abstract][Full Text] [Related]
5. Recurrent SMARCB1 Mutations Reveal a Nucleosome Acidic Patch Interaction Site That Potentiates mSWI/SNF Complex Chromatin Remodeling.
Valencia AM; Collings CK; Dao HT; St Pierre R; Cheng YC; Huang J; Sun ZY; Seo HS; Mashtalir N; Comstock DE; Bolonduro O; Vangos NE; Yeoh ZC; Dornon MK; Hermawan C; Barrett L; Dhe-Paganon S; Woolf CJ; Muir TW; Kadoch C
Cell; 2019 Nov; 179(6):1342-1356.e23. PubMed ID: 31759698
[TBL] [Abstract][Full Text] [Related]
6. Smarcb1 maintains the cellular identity and the chromatin landscapes of mouse embryonic stem cells.
Sakakura M; Ohta S; Yagi M; Tanaka A; Norihide J; Woltjen K; Yamamoto T; Yamada Y
Biochem Biophys Res Commun; 2019 Nov; 519(4):705-713. PubMed ID: 31543342
[TBL] [Abstract][Full Text] [Related]
7. Phosphoproteomic analysis reveals Smarcb1 dependent EGFR signaling in Malignant Rhabdoid tumor cells.
Darr J; Klochendler A; Isaac S; Geiger T; Eden A
Mol Cancer; 2015 Sep; 14():167. PubMed ID: 26370283
[TBL] [Abstract][Full Text] [Related]
8. A recurrent de novo missense pathogenic variant in SMARCB1 causes severe intellectual disability and choroid plexus hyperplasia with resultant hydrocephalus.
Diets IJ; Prescott T; Champaigne NL; Mancini GMS; Krossnes B; Frič R; Kocsis K; Jongmans MCJ; Kleefstra T
Genet Med; 2019 Mar; 21(3):572-579. PubMed ID: 29907796
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
[TBL] [Abstract][Full Text] [Related]
10. Smarcb1 Loss Results in a Deregulation of esBAF Binding and Impacts the Expression of Neurodevelopmental Genes.
Alfert A; Walter C; Moreno N; Melcher V; Graf M; Hotfilder M; Dugas M; Albert T; Kerl K
Cells; 2022 Apr; 11(8):. PubMed ID: 35456033
[TBL] [Abstract][Full Text] [Related]
11. SMARCB1-mediated SWI/SNF complex function is essential for enhancer regulation.
Wang X; Lee RS; Alver BH; Haswell JR; Wang S; Mieczkowski J; Drier Y; Gillespie SM; Archer TC; Wu JN; Tzvetkov EP; Troisi EC; Pomeroy SL; Biegel JA; Tolstorukov MY; Bernstein BE; Park PJ; Roberts CW
Nat Genet; 2017 Feb; 49(2):289-295. PubMed ID: 27941797
[TBL] [Abstract][Full Text] [Related]
12. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
[TBL] [Abstract][Full Text] [Related]
13. Premature termination of SMARCB1 translation may be followed by reinitiation in schwannomatosis-associated schwannomas, but results in absence of SMARCB1 expression in rhabdoid tumors.
Hulsebos TJ; Kenter S; Verhagen WI; Baas F; Flucke U; Wesseling P
Acta Neuropathol; 2014 Sep; 128(3):439-48. PubMed ID: 24740647
[TBL] [Abstract][Full Text] [Related]
14. Whole Exome- and mRNA-Sequencing of an AT/RT Case Reveals Few Somatic Mutations and Several Deregulated Signalling Pathways in the Context of SMARCB1 Deficiency.
Sandgren J; Holm S; Marino AM; Asmundsson J; Grillner P; Nistér M; Díaz de Ståhl T
Biomed Res Int; 2015; 2015():862039. PubMed ID: 26998479
[TBL] [Abstract][Full Text] [Related]
15. Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations.
Stockman DL; Curry JL; Torres-Cabala CA; Watson IR; Siroy AE; Bassett RL; Zou L; Patel KP; Luthra R; Davies MA; Wargo JA; Routbort MA; Broaddus RR; Prieto VG; Lazar AJ; Tetzlaff MT
J Cutan Pathol; 2015 May; 42(5):308-17. PubMed ID: 25754356
[TBL] [Abstract][Full Text] [Related]
16. Loss of expression of SMARCA4 (BRG1), SMARCA2 (BRM) and SMARCB1 (INI1) in undifferentiated carcinoma of the endometrium is not uncommon and is not always associated with rhabdoid morphology.
Ramalingam P; Croce S; McCluggage WG
Histopathology; 2017 Feb; 70(3):359-366. PubMed ID: 27656868
[TBL] [Abstract][Full Text] [Related]
17. A Role for SMARCB1 in Synovial Sarcomagenesis Reveals That SS18-SSX Induces Canonical BAF Destruction.
Li J; Mulvihill TS; Li L; Barrott JJ; Nelson ML; Wagner L; Lock IC; Pozner A; Lambert SL; Ozenberger BB; Ward MB; Grossmann AH; Liu T; Banito A; Cairns BR; Jones KB
Cancer Discov; 2021 Oct; 11(10):2620-2637. PubMed ID: 34078620
[TBL] [Abstract][Full Text] [Related]
18. Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination.
Langer LF; Ward JM; Archer TK
Elife; 2019 Apr; 8():. PubMed ID: 31033435
[TBL] [Abstract][Full Text] [Related]
19. Loss of IGFBP7 expression and persistent AKT activation contribute to SMARCB1/Snf5-mediated tumorigenesis.
Darr J; Klochendler A; Isaac S; Eden A
Oncogene; 2014 Jun; 33(23):3024-32. PubMed ID: 23851500
[TBL] [Abstract][Full Text] [Related]
20. Germline SMARCB1 mutation predisposes to multiple meningiomas and schwannomas with preferential location of cranial meningiomas at the falx cerebri.
van den Munckhof P; Christiaans I; Kenter SB; Baas F; Hulsebos TJ
Neurogenetics; 2012 Feb; 13(1):1-7. PubMed ID: 22038540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]